leema.ai Overview
Leema.ai is a digital health company that specializes in tailoring treatment plans for medical cannabis patients. Through its AI-powered platform, the company offers real-time insights, data-driven treatment recommendations, and continuous monitoring to enhance patient outcomes. Leema.ai has a demonstrated history of delivering effective treatment plans for more than 15,000 patients across Israel and the United States.
Cumulative Funding Raised Over Time ($)
Latest News
Neutral
[Opinion] New restrictions on medical cannabis: what are the changes and what are the consequences?
The article discusses new guidelines issued by the Israeli Ministry of Healths Medical Cannabis Unit. The guidelines limit the amount of THC and cannabis that can be prescribed to new patients. The author, Danny Reiss, founder and CEO of leema.ai, a digital treatment platform for personalized medical cannabis treatment, criticizes these guidelines. He argues that they could hinder treatments, especially for patients transitioning from opioids to cannabis. He calls for the return of decision-making power to practitioners and patients.
Management Changes
N/A
leema.ai chosen to participate in the - BizLabs MedTech digital healthtech scalerator
The text appears to be a list of links or headlines related to various topics, possibly related to the Israeli media and telecommunications industry. Specific companies or individuals mentioned include Bezeq, Yes, Cellcom, and IBC, as well as individuals such as Moshe Kahlon, Shlomo Filber, and Ayoub Kara. The text also refers to various cases or files, possibly referring to legal or regulatory issues. However, without further context or access to the full articles, it is difficult to provide a comprehensive summary or analysis.
N/A
How to pick your monthly strains?
growth-positive
Introducing your cannabis personal assistant - leema.ai
Israeli startup LEEMA has launched a new application for medical cannabis patients. The app analyses consumption habits using a unique tracking interface to optimise treatment, maximise dosage efficiency, and find the most suitable strain for the patient. The app aims to save patients time and money by avoiding ineffective or suboptimal products for their specific condition. It also serves as a solid knowledge base for renewing prescriptions and obtaining long-term treatment approval according to the strict monitoring criteria of the Ministry of Health. The app is designed to serve the patients most important personal need: successful treatment and achieving maximum results in the shortest possible time.
CustomersExpand
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $200K |
| Last funding | $200K |
| Stage | Pre-Seed |
| Rounds | 1 |
| Investors | 1 |
Team Members
5
Employees: 1-10
Web & Social Links
| Website | www.leema.ai |
| App Store | App Store |
| Google Play | Google Play |
Locations
Ariel Sharon St 4, Giv'atayim, Israel
Photos & Videos
5 item(s)
